Objective
To determine whether the Bundled Payments for Care Improvement (BPCI) initiative affected patient‐reported measures of quality.
Data Sources
Surveys of Medicare fee‐for‐service beneficiaries discharged from acute care hospitals participating in BPCI Model 2 and comparison hospitals between October 2014 and June 2017. Variables from Medicare administrative data and the Provider of Services file were used for sampling and risk adjustment.
Study Design
We estimated risk‐adjusted differences in patient‐reported measures of care experience and changes in functional status, for beneficiaries treated by BPCI and comparison hospitals.
Data Collection
We selected a stratified random sample of BPCI and matched comparison beneficiaries. We fielded nine waves of surveys using a mail and phone protocol, yielding 29 193 BPCI and 29 913 comparison respondents.
Principal Findings
Most BPCI and comparison survey respondents reported a positive care experience and high satisfaction. BPCI respondents were slightly less likely than comparison respondents to report positive care experience or high satisfaction. Despite these differences in care experience, there was no difference between BPCI and comparison respondents in self‐reported functional status approximately 90 days after hospital discharge.
Conclusions
These findings reduce concerns that BPCI may have unintentionally harmed patient health but suggest room for improvement in patient care experience.
Innovations in workforce training and technology specific to the ICU may be useful in addressing the shortage of intensivist physicians, yielding benefits to patients and payers.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.